Spectrum Pharmaceuticals Inc
SPPI
Common Stock
$1.03
Sector: Health Care
Industry: Biotechnology
Sub-Industry: Biotechnology
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$1.02 | -$1.29 | -$1.02 | -$1.17 | -$1.07 |
Sales/Revenue | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $128.37 M |
Sales Growth | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$158.44 M | -$171.27 M | -$135.39 M | -$126.71 M | -$91.25 M |
Net Income Growth | 7.49% | -26.51% | -6.85% | -38.86% | 0.00% |
Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$140.89 M | -$167.93 M | -$136.88 M | -$137.65 M | -$68.69 M |
Cost of Goods Sold (incl D&A) | $1.91 M | $1.80 M | $2.12 M | $0.20 M | $74.87 M |
Cost of Goods Sold (excl D&A) | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $46.89 M |
Cost of Goods Growth | 6.05% | -14.85% | 957.50% | -99.73% | 0.00% |
Research & Development | $87.30 M | $109.38 M | $79.13 M | $75.16 M | $65.90 M |
Other SG&A Expenses | $0.00 M | $58.56 M | $57.76 M | $62.49 M | $84.27 M |
Interest Expense | $0.00 M | $0.00 M | $0.00 M | $0.34 M | $6.80 M |
Income Tax | $0.00 M | -$0.06 M | -$9.21 M | -$1.90 M | -$16.78 M |
2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.12 | -$0.17 | -$0.09 | -$0.26 |
Sales/Revenue | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Sales Growth | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$21.93 M | -$29.05 M | -$15.40 M | -$39.75 M |
Net Income Growth | 24.50% | -88.58% | 61.25% | -20.19% |
Net Margin | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$21.60 M | -$24.95 M | -$13.63 M | -$31.41 M |
Cost of Goods Sold (incl D&A) | $0.00 M | $0.44 M | $0.43 M | $0.55 M |
Cost of Goods Sold (excl D&A) | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 0.00% | 2.09% | -21.21% | 19.17% |
Research & Development | $13.34 M | $16.01 M | $4.19 M | $17.96 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Interest Expense | $0.10 M | $0.00 M | $0.00 M | $0.00 M |
Income Tax | $0.02 M | $0.01 M | $0.02 M | -$0.01 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $2.96 M | $5.82 M | $15.41 M | $0.39 M | $0.59 M |
Cash and Short-Term Investment | $100.65 M | $180.03 M | $223.87 M | $203.99 M | $227.57 M |
Cash and Short-Term Investment Growth | -44.09% | -19.59% | 9.75% | -10.36% | 0.00% |
Long Term Debt | $1.45 M | $0.88 M | $2.37 M | $0.00 M | $0.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $111.55 M | $196.80 M | $263.43 M | $403.20 M | $493.29 M |
Total Assets Growth | -43.32% | -25.29% | -34.66% | -18.26% | 0.00% |
Inventories | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $5.72 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $5.19 M |
Short Term Debt | $1.28 M | $1.54 M | $1.68 M | $0.00 M | $38.22 M |
Total Liabilities | $64.00 M | $62.56 M | $73.04 M | $131.79 M | $141.95 M |
2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $2.29 M | $2.05 M | $2.53 M | $2.96 M | $3.39 M |
Cash and Short-Term Investment | $100.25 M | $67.96 M | $89.21 M | $100.65 M | $133.60 M |
Cash and Short-Term Investment Growth | 47.52% | -23.82% | -11.36% | -24.66% | 0.00% |
Long Term Debt | $29.74 M | $1.14 M | $1.30 M | $1.45 M | $1.59 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $118.93 M | $79.43 M | $100.05 M | $111.55 M | $147.80 M |
Total Assets Growth | 49.73% | -20.61% | -10.30% | -24.53% | 0.00% |
Inventories | $9.37 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $0.75 M | $0.72 M | $1.00 M | $1.28 M | $1.45 M |
Total Liabilities | $83.08 M | $45.99 M | $44.80 M | $64.00 M | $68.34 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|
Quarter | Amount | Yield |
---|---|---|
2012 Q4
|
$0.15
|
14.60%
|
|
|